These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4920940)

  • 1. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL
    Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of botulin toxins and anatoxins by the gel filtration method. I. Studies of botulin toxins and anatoxins types A and C by filtration through Sephadex G-100].
    Freĭman VB; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):52-8. PubMed ID: 4975811
    [No Abstract]   [Full Text] [Related]  

  • 7. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of type E botulinal toxin in cultures by fluorescent-antibody microscopy.
    Aalvik B; Sakaguchi G; Riemann H
    Appl Microbiol; 1973 Jan; 25(1):153-4. PubMed ID: 4568886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological specificity of type E botulinal toxin.
    Johnson HM; Smith BG; Lewis KH
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):973-6. PubMed ID: 4997865
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 13. [The antigenic structure of the toxins of Clostridium botulinum, type C strains, isolated in the USSR].
    Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug; 42(8):79-84. PubMed ID: 5334428
    [No Abstract]   [Full Text] [Related]  

  • 14. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of comparative experimental examinations of the therapeutic effect of antitoxin, formol toxoid and the combination of both on Cl. botulinum-(D)-toxin produced intoxication].
    KATIC RV
    Zentralbl Bakteriol Orig; 1956 Aug; 166(6):510-6. PubMed ID: 13361428
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic activity of the combined botulinum toxoids].
    Trembowler P; Switalska A; Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(2):161-8. PubMed ID: 4913814
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissociation of Clostridium botulinum type-E-toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochem Biophys Res Commun; 1967 Dec; 29(6):892-7. PubMed ID: 4965663
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.